Biotech Sapience Therapeutics Presents Clinical Data on Two Lead Programs, Including ST101 Oral Presentation, at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting November 10, 2024
Biotech WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO November 8, 2024
Biotech Naitive® and Parvizi Surgical Innovation Partner to Advance Osteoporosis Detection November 7, 2024
Biotech Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma November 6, 2024
Biotech NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink November 5, 2024
Biotech Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 4, 2024
Biotech Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds November 3, 2024
Biotech Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 2, 2024
Search
Biotech
November 10, 2024
November 9, 2024
November 8, 2024
November 7, 2024
November 6, 2024
November 5, 2024
November 4, 2024
November 3, 2024
November 2, 2024
November 1, 2024
